AMIX — Autonomix Medical Income Statement
0.000.00%
Last trade - 00:00- $4.93m
- -$5.77m
- 18
- 50
- 17
- 18
Annual income statement for Autonomix Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 13.4 | 1.99 | 12 |
| Operating Profit | -13.4 | -1.99 | -12 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -13.3 | -1.99 | -15.4 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -13.3 | -1.99 | -15.4 |
| Net Income Before Extraordinary Items | |||
| Net Income | -13.3 | -1.99 | -15.4 |
| Adjustments to Net Income | |||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -12.8 | -1.99 | -15.4 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -12.3 | -1.89 | -16.4 |